In the midst of pandemic upheaval, researchers have gained fundamental insights about how the body fends off infections.

Despite long COVID’s vast reach, and more than $1 billion spent on research, no new treatments have been brought to market.

Four in 10 Minnesotans who contracted COVID-19 reported in a new state survey that they struggled with lingering health ...

It’s been estimated that about 400 million people worldwide have had long COVID. Some researchers say that number is much ...

The chronic illnesses that make doctors doubt their patients often start after what “should” be a short-lived sickness—like ...

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.

OneBlood is the first blood center to get full FDA approval to give high-titer COVID-19 convalescent plasma to those with COVID-19 who are also immunocompromised.

Friday marked five years since a suburban hospital announced it was treating the first confirmed COVID-19 patient in Illinois ...

Seasonal influenza, respiratory syncytial virus (RSV), and COVID-19 are actively circulating throughout the United States.

A national shortage in a common treatment for attention-deficit hyperactivity disorder was associated with changes in stimulant prescriptions filled for children over recent years, a new study ...

Dr. Adrien Eshraghi, a surgeon-scientist, specializes in hearing disorders and focuses his research on helping patients like Kelsie Gonzalez.